Cleo Diagnostics Ltd (ASX:COV)
Australia · Delayed Price · Currency is AUD 0.3400
0.00 (0.00%)
Last updated: Aug 28, 2026, 2:11 PM AEST
Cleo Diagnostics Market Cap
Cleo Diagnostics has a market cap or net worth of 46.62 million as of August 28, 2026. Its market cap has increased by 0.77% in one year.
Market Cap
46.62M
Enterprise Value
40.39M
Revenue
1.72M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.34
ChartMarket Cap Chart
Since August 15, 2023, Cleo Diagnostics's market cap has increased from 25.70M to 46.62M, an increase of 81.39%. That is a compound annual growth rate of 21.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 47.30M | -42.87% |
| Dec 31, 2025 | 82.80M | 81.51% |
| Dec 31, 2024 | 45.62M | 102.86% |
| Dec 29, 2023 | 22.49M | -12.50% |
| Aug 15, 2023 | 25.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lumos Diagnostics Holdings | 94.44M |
| Epiminder | 78.97M |
| SomnoMed | 72.30M |
| Cyclopharm | 64.12M |
| Compumedics | 50.94M |
| HeraMED | 41.67M |
| Nova Eye Medical | 39.88M |
| OncoSil Medical | 35.52M |